210 related articles for article (PubMed ID: 15778394)
1. Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes.
Inoue T; Hammaker D; Boyle DL; Firestein GS
J Immunol; 2005 Apr; 174(7):4301-6. PubMed ID: 15778394
[TBL] [Abstract][Full Text] [Related]
2. Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis.
Chabaud-Riou M; Firestein GS
Am J Pathol; 2004 Jan; 164(1):177-84. PubMed ID: 14695331
[TBL] [Abstract][Full Text] [Related]
3. Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.
Yoshizawa T; Hammaker D; Boyle DL; Corr M; Flavell R; Davis R; Schett G; Firestein GS
J Immunol; 2009 Jul; 183(2):1360-7. PubMed ID: 19561096
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis.
Inoue T; Boyle DL; Corr M; Hammaker D; Davis RJ; Flavell RA; Firestein GS
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5484-9. PubMed ID: 16567640
[TBL] [Abstract][Full Text] [Related]
5. MKK3/6-p38 MAPK negatively regulates murine MMP-13 gene expression induced by IL-1beta and TNF-alpha in immortalized periodontal ligament fibroblasts.
Rossa C; Liu M; Patil C; Kirkwood KL
Matrix Biol; 2005 Oct; 24(7):478-88. PubMed ID: 16046111
[TBL] [Abstract][Full Text] [Related]
6. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.
Li Y; Batra S; Sassano A; Majchrzak B; Levy DE; Gaestel M; Fish EN; Davis RJ; Platanias LC
J Biol Chem; 2005 Mar; 280(11):10001-10. PubMed ID: 15644321
[TBL] [Abstract][Full Text] [Related]
7. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1.
McDermott EP; O'Neill LA
J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690
[TBL] [Abstract][Full Text] [Related]
8. Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus.
Jin Y; Fan Y; Yan EZ; Liu Z; Zong ZH; Qi ZM
Acta Pharmacol Sin; 2006 Oct; 27(10):1309-16. PubMed ID: 17007737
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
Huang H; Ryu J; Ha J; Chang EJ; Kim HJ; Kim HM; Kitamura T; Lee ZH; Kim HH
Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
[TBL] [Abstract][Full Text] [Related]
10. Effects of constitutively active and dominant negative MAPK kinase (MKK) 3 and MKK6 on the pH-responsive increase in phosphoenolpyruvate carboxykinase mRNA.
O'Hayre M; Taylor L; Andratsch M; Feifel E; Gstraunthaler G; Curthoys NP
J Biol Chem; 2006 Feb; 281(5):2982-8. PubMed ID: 16319064
[TBL] [Abstract][Full Text] [Related]
11. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation.
Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L
Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151
[TBL] [Abstract][Full Text] [Related]
12. TACE-dependent amphiregulin release is induced by IL-1β and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis.
Liu FL; Wu CC; Chang DM
Rheumatology (Oxford); 2014 Feb; 53(2):260-9. PubMed ID: 24196392
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Mimata Y; Kamataki A; Oikawa S; Murakami K; Uzuki M; Shimamura T; Sawai T
Int J Rheum Dis; 2012 Feb; 15(1):36-44. PubMed ID: 22324945
[TBL] [Abstract][Full Text] [Related]
14. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways.
Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F
Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation.
Umar S; Hedaya O; Singh AK; Ahmed S
Toxicol Appl Pharmacol; 2015 Sep; 287(3):299-305. PubMed ID: 26134265
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H
Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus (FK506) inhibits interleukin-1β-induced angiopoietin-1, Tie-2 receptor, and vascular endothelial growth factor through down-regulation of JNK and p38 pathway in human rheumatoid fibroblast-like synoviocytes.
Choe JY; Lee SJ; Park SH; Kim SK
Joint Bone Spine; 2012 Mar; 79(2):137-43. PubMed ID: 21550286
[TBL] [Abstract][Full Text] [Related]
19. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
[TBL] [Abstract][Full Text] [Related]
20. Role of MKK3 and p38 MAPK in cytokine-induced death of insulin-producing cells.
Makeeva N; Myers JW; Welsh N
Biochem J; 2006 Jan; 393(Pt 1):129-39. PubMed ID: 16097952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
